Shares of Abbott Laboratories plunged 10.04% to $108.61 Thursday, on what proved to be an all-around great trading session ...

Quick Read Rocket Lab (RKLB) had a Stage 1 tank rupture during Neutron qualification testing. The stock fell 5.5% in morning ...

Rocket Lab (RKLB)’s stock surged 45%, driven not only by a robust 10% increase in revenue but also by a significant 36% ...

Rocket Lab completes its first 2026 launch, deploying two satellites for Open Cosmos. Electron rocket proves reliable and ...

Because they’re losing cash rapidly. Operating losses of $229 million result in a -41% operating margin. They burned $103 ...

Abbott Laboratories stock has reached a 52-week low, closing at $107.27. This marks a notable point for the healthcare company, as it navigates a challenging market environment. Over the past year, ...

Rocket Lab stock has continued to skyrocket in 2026 and is currently up 38% year to date. Meanwhile, the S&P 500 is up 1.4%, ...

Wondering if Rocket Lab’s soaring share price still makes sense for your portfolio, or if the value story is already ...

Rocket Lab looks overvalued despite Neutron/defense catalysts. Click here for more on the RKLB stock prospects.

Rocket Lab’s stock price already reflects the impact of major recent milestones and renewed enthusiasm for the space sector, ...

Rocket Lab is surging on massive contracts and backlog growth, but this one factor could decide whether the stock keeps ...

Rocket Lab USA (NASDAQ:RKLB) shares jumped about 6% on Friday after Morgan Stanley upgraded the stock from Equalweight to ...